Cue Biopharma Inc expected to post a loss of 42 cents a share - Earnings Preview
04/08/2021 02:43
* Cue Biopharma Inc CUE.OQ CUE.O is expected to show a fall
in quarterly revenue when it reports results on August 5
(estimated).
* The Cambridge, Massachusetts-based company is expected to
report a 1.7% decrease in revenue to $1.057 million from $1.08
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cue Biopharma Inc is
for a loss of 42 cents per share. For the same quarter last
year, the company reported a loss of 38 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by about 0.5%
in the last three months.
* Wall Street's median 12-month price target for Cue Biopharma
Inc is $30, about 65.2% above its last closing price
of $10.45.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.38 -0.38 -0.41 Missed -8.5
Dec. 31 2020 -0.35 -0.35 -0.36 Missed -2.9
Sep. 30 2020 -0.39 -0.38 -0.34 Beat 11.5
Jun. 30 2020 -0.44 -0.43 -0.38 Beat 10.8
Mar. -0.35 -0.35 -0.48 Missed -37.1
31 2020
Dec. 31 2019 -0.42 -0.45 -0.36 Beat 19.6
Sep. 30 2019 -0.44 -0.44 -0.31 Beat 29.5
Jun. 30 2019 -0.56 -0.56 -0.46 Beat 17.9
This summary was machine generated August 4 at 01:43 GMT. All
figures in US dollars unless otherwise stated